X

Trial Profile

Restoring Insulin Secretion Adult Medication Study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 May 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin glargine (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
Indications Prediabetic state; Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms RISE Adult

Most Recent Events

12 May 2023 Status changed from active, no longer recruiting to completed.
16 Jun 2021 Results from the three RISE study (NCT01779362, NCT01779375 and NCT01763346) assessing the effect of Liraglutide and metformin in adults would improve a-cell function beyond any potential effect of weight loss, published in the Diabetes Care.
15 Jun 2021 Results assessing the comparing the glycemic worsening between youth and adult RISE participants with IGT or recently diagnosed type 2 diabetes and identify baseline characteristics that predict glycemic worsening in each group, published in the Diabetes Care.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com